Session Chair Profile

Ph.D., Director, Population Health, Olink

Biography
Cindy is passionate about innovation to make genetic and multi-omic technologies easier and cheaper to measure. She sees such innovation as pivotal to lower the barrier of entry for implementing scalable, reproducible solutions advancing individualized medicine and health equity. In over 14 years at Illumina and together with customers, she helped develop solutions to advance the understanding of genetic risk and holds several USDA Excellence in Technology Transfer awards for her work leading Illumina’s Consortia Program. She joined Olink in 2020 soon after the launch of the Explore Platform that leverages next generation sequencing as a high throughput proteomic readout. Ask her about how high throughput proteomics are helping translate the impact our genetics has on more real time health.


 Session Abstract – PMWC 2023 Silicon Valley

Track 4 - January 25 9.00 A.M.-4.45 P.M.


Track Chair: Cindy Lawley, Olink

  • How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs
    Chair: Keith Yamamoto, UCSF
    - Douglas Friedman, Engineering Biology Research Consortium (EBRC)
    - Jay Keasling, JBEI (Joint BioEnergy Institute)
    - Renee Wegrzyn, ARPA-H
  • Moving Sequencing into the Clinical Setting
    Chair: Charles Chiu, UCSF
    - Charlotte Hobbs, Rady Children’s Hospital
    - Euan Ashley, Stanford University
    - Sivan Bercovici, Karius
    - Heike Sichtig, Foundation Medicine
  • Evolving Sequencing Applications: Spatial Single-Cell Multi-Omics
    Chair: Michael Rhodes, NanoString
    - Chrstina Curtis, Stanford
  • How will Cheap Genome Sequencing Impact Genomic Medicine (PANEL)
    Chair: Euan Ashley, Stanford
    - Shawn Levy, Element Biosciences
    - Aleks Rajkovic, UCSF
    - David Bentley, Illumina
    - Stacey Gabriel, Broad Inst.
    - Sean Hofherr, Fabric Genomics
  • Single-cell, Spatial, and in Situ Technologies
    Chair: Dina Finan, 10x Genomics
    - Carina Emery, Miltenyi Biotec
  • Combining WGS with a AI-based Tumor Enrichment Method
    Chair: Asaf Zviran, C2I
  • Multi-omics Approaches Supporting Clinical Translation
    Chair: Cindy Lawley, Olink
    - Erin Smith, Takeda
    - Si Wu, Stanford
    - Christopher Whelan, J&J
  • Molecular Diagnosis New standard with NGS for Neurological and Infectious Conditions
    Chair: Scott Rabuka, DNA Genotek
    - Forrest Wright, Quadrant Laboratories
    - Frank Middleton, SUNY Upstate Medical University
  • PMWC Showcase
    - Josh Lauer, Ultime
    - Olivier Lucas, Oxford Nanopore
    - Lukasz Boryn, Ardigen